Watson, Sinead
Moore, Sophie E.
Darboe, Momodou K.
Chen, Gaoyun
Tu, Yu-Kang
Huang, Yi-Ting
Eriksen, Kamilla G.
Bernstein, Robin M.
Prentice, Andrew M.
Wild, Christopher P.
Xu, Ya
Routledge, Michael N. http://orcid.org/0000-0001-9139-2182
Gong, Yun Yun
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1 066947)
Article History
Received: 10 May 2018
Accepted: 30 October 2018
First Online: 9 November 2018
Ethics approval and consent to participate
: Ethical approval for the ENID trial, the ENID-Growth add-on and this sub-study was obtained by the joint Gambian Government/Medical Research Council (MRC) Unit The Gambia ethics committee. Additional approval for this sub-study was obtained from the University of Leeds ethics committee. Written informed consent was obtained from all participants.
: Not applicable.
: All authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.